This note develops a simple model in which an upstream monopolist sells an input used by two downstream competitors.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...

